Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta‐analysis
Addiction · 2024
DOI: 10.1111/add.16370 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Addiction, 2024. Verfasst von Maryam Sorkhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Centre for Addiction and Mental Health, National Institute on Drug Abuse.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Aims Δ9‐tetrahydrocannabinol (THC), the principal psychoactive component of cannabis, has been implicated in affecting fetal neurodevelopment by readily crossing the placenta. However, little is known regarding the long‐term effects of intrauterine cannabis exposure. This systematic review and meta‐analysis synthesized prospective and cross‐sectional human studies to measure the effects of intrauterine cannabis exposure on birth, behavioral, psychological and cognitive outcomes in infancy until early childhood.
Methods
Reporting according to the Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) statement, cross‐sectional and prospective studies published from database inception until June 2023, investigating developmental outcomes of infants, toddlers and young children with intrauterine cannabis exposure were considered. All articles were obtained from PubMed or PsycINFO databases.
Results
The literature search resulted in 932 studies, in which 57 articles met eligibility criteria. The meta‐analysis revealed that intrauterine cannabis exposure increases the risk of preterm delivery [odds ratio (OR) = 1.68, 95% confidence interval (CI) = 1.05–2.71, P = 0.03], low birth weight (OR = 2.60, CI = 1.71–3.94, P < 0.001) and requirement for neonatal intensive care unit (NICU) admission (OR = 2.51, CI = 1.46–4.31; P < 0.001). Our qualitative synthesis suggests that intrauterine cannabis exposure may be associated with poorer attention and externalizing problems in infancy and early childhood. We found no evidence for impairments in other cognitive domains or internalizing behaviors.
Conclusions
Prenatal cannabis use appears to be associated with lower birth weight, preterm birth and neonatal intensive care unit admission in newborns, but there is little evidence that prenatal cannabis exposure adversely impacts behavioral or cognitive outcomes in early childhood, with the exception of attention and externalizing problems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada.
- Institute of Medical Sciences, Department of Psychiatry, University of Toronto, ON, Canada.
- Tasmania Centre for Mental Health Service Innovation, University of Tasmania, Hobart, Australia.
ORCID-Profile: Maryam Sorkhou
Förderung
- NIDA NIH HHS
- Centre for Addiction and Mental Health
- National Institute on Drug Abuse
Zitieren
APA
Sorkhou, M., Singla, D. R., Castle, D. J., & George, T. P. (2024). Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta‐analysis. Addiction. https://doi.org/10.1111/add.16370
Vancouver
Sorkhou M, Singla DR, Castle DJ, George TP. Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta‐analysis. Addiction. 2024. doi:10.1111/add.16370
BibTeX
@article{Sorkhou2024,
author = {Sorkhou, Maryam and Singla, Daisy R and Castle, David J and George, Tony P},
title = {Birth, cognitive and behavioral effects of intrauterine cannabis exposure in infants and children: A systematic review and meta‐analysis},
journal = {Addiction},
year = {2024},
doi = {10.1111/add.16370}
}
EUVIMED